Inspirational Team of Athletes – Team Type 1 – Spreads Messages of Hope to Others with Diabetes and Steers Toward Its Ultimate Goal of Tour de France Competition
New Data Suggest That Despite Knowing the Risk of Self-Medication, 76 Percent of American Adults Use Non-Prescription Medications for Themselves and Their Children
Fifth- annual program to convey vital messages about reducing risks of a condition with a complication that is the most common cause of preventable hospital death
Clinical study demonstrates breakthrough dose-sparing formulation that increases stockpile capacities and expands potential production capacities to billions of doses in a pandemic situation
If approved, Pentacel vaccine would be the first pediatric combination vaccine in the U.S. to immunize against diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (Hib)
Record production capabilities strengthen sanofi pasteur’s global leadership in the fight against seasonal influenza and place the company at the forefront of pandemic readiness
The PREVAIL study showed that in acute ischemic stroke patients treated with Lovenox, the risk of having a VTE was lowered by a significant 43% with no statistically significant increase in clinically important bleedings when compared to UFH
Comparative Clinical Trial Results Announced for the Treatment of Nasolabial Folds at the 2006 American Society of Dermatologic Surgery (ASDS) Annual Meeting
Taxotere(R)-based regimen demonstrates a significantly longer progression free survival and 29 percent reduction in the risk of mortality in patients with inoperable locally advanced head and neck cancer
As communicated by CDC, majority of supply will be available in October and November; sanofi pasteur shipped one-third of influenza vaccine planned for 2006-2007 season
